# FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA

> **NCT06135298** · PHASE4 · COMPLETED · sponsor: **Aksaray University** · enrollment: 20 (actual)

## Conditions studied

- Trochanteric Fracture of Femur
- Osteoporotic Fracture of Femur
- Hip Fractures
- Bone Density, Low

## Interventions

- **PROCEDURE:** OSTEOSYNTHESIS
- **DRUG:** Zoledronic acid
- **DEVICE:** CERAMENT BONE VOID FILLER (BVF)

## Key facts

- **NCT ID:** NCT06135298
- **Lead sponsor:** Aksaray University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2026-01-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135298, "FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06135298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*